Category Health Tech

For the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia

In a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s The Feinstein Institutes for Medical Research have successfully implanted microchips into the brain of a man living with paralysis,…

Read MoreFor the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia

bspr Inc. and BHQ Corp. to Release First Smartphone App “Braincure” Beta Version Encompassing BHQ Actions for Brain Health, in the United States in September

bspr Inc. (Shibuya-ku, Tokyo, CEO: Yosuke Toyama), in collaboration with BHQ Corp. (Saitama City, Saitama Prefecture, CEO: Masahito Kawamori), is pleased to announce the release of the beta version of…

Read Morebspr Inc. and BHQ Corp. to Release First Smartphone App “Braincure” Beta Version Encompassing BHQ Actions for Brain Health, in the United States in September

Impetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding. Hevolution Foundation, a global non-profit…

Read MoreImpetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma

Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating the development of promising treatments to market announced the FDA authorization of a Phase II clinical trial to re-assess a targeted…

Read MoreUnited States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma

n-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients

n-Lorem, a nonprofit foundation, today announced the publication of an article in Nature Biotechnology (Crooke, S.T., et al. Nature Biotechnology advanced online publication, July 2023). In this publication, Dr. Crooke and colleagues describe the…

Read Moren-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients

World Materials & Tools for Point-of-Care & Rapid Diagnostics Development Conference 2023: Revolutionizing Point-of-Care Diagnostics – Join Us at MTPRD 2023 in Laguna Hills (November 28-30, 2023) – ResearchAndMarkets.com

Welcome to the Materials & Tools for Point-of-Care & Rapid Diagnostics Development 2023 Conference to be held in-person on-site in beautiful Laguna Hills, California. Bringing together researchers and industry participants…

Read MoreWorld Materials & Tools for Point-of-Care & Rapid Diagnostics Development Conference 2023: Revolutionizing Point-of-Care Diagnostics – Join Us at MTPRD 2023 in Laguna Hills (November 28-30, 2023) – ResearchAndMarkets.com

HRC Fertility Celebrates 35 Years in The Business with New Program Making Egg Freezing Accessible and More Affordable

HRC Fertility Center, one of the largest providers of advanced fertility treatments based in Southern California, announced the celebration of its 35th anniversary by unveiling special egg freezing packages including…

Read MoreHRC Fertility Celebrates 35 Years in The Business with New Program Making Egg Freezing Accessible and More Affordable